EVOLVA N overview

Evolva Holding SA / Key word(s): Agreement Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026 05-May-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to...

Evolva Holding SA / Key word(s): AGMEGM Evolva publishes timeline of the Reverse Stock Split 24.04.2023 / 07:00 CET/CEST Reinach, 24 April 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, today communicates on the timeline of the reverse stock split of 250:1 which was approved by shareholders at the Annual General Meeting on 18 April 2023 by a large majority: 25 April 2023: Last trading day of old shares on SIX Swiss Exchange 26 April 2023: First...

Evolva Holding SA / Key word(s): AGMEGM Evolva shareholders approve all motions proposed by the Board at today’s Annual General Meeting 18.04.2023 / 17:30 CET/CEST Press Release (PDF) The shareholders approved, among others: The Reverse stock split of 250:1, followed by a reduction of the par value of the shares to CHF 1.00 Introduction of a capital band of up to +/- 20% of current share capital Re-election of all board members and election of Stephan Schindler as Chairperson, ensuring...

Evolva Holding SA / Key word(s): Product Launch Evolva goes Responsible Care at in-cosmetics 2023 28.03.2023 / 07:00 CET/CEST Press Release (PDF) PRESS RELEASE Evolva is globally launching an exclusive line of nature-based high-purity ingredients and bio-functionals for the personal care industry, produced in a sustainable manner New science backed up by proprietary research studies by Evolva unlock an innovative spectrum of cosmetic claims for topical skin and scalp applications This enables...

Evolva Holding SA / Key word(s): AGMEGM Evolva publishes agenda for 2023 Annual General Meeting 24-March-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad Hoc Announcement (PDF) PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Board of Directors proposes, among others, the following to the shareholders: Reverse stock split of 250:1, followed by a reduction of the nominal value of the...

Evolva Holding SA / Key word(s): Annual Results Evolva delivers accelerated revenue growth of 57% in 2022 and substantially improved profitability profile 09-March-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad Hoc Announcement (PDF) PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Reinach, 9 March 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and...